Search results
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffs
WSAU Wausau· 4 hours ago(Reuters) - Eli Lilly has entered into a settlement deal with a medi spa that had sold counterfeit...
Lilly Settles With Spa Selling Mounjaro, Zepbound Knock-Offs
The Wall Street Journal· 6 hours agoEli Lilly has reached its first legal settlement with one of the spas that it had accused in...
Is Eli Lilly's Latest Deal a Gamechanger? | The Motley Fool
The Motley Fool· 15 hours agoDiabetes and obesity treatments from Novo Nordisk, such as Ozempic, Rybelsus, and Wegovy, are taking...
Eli Lilly Allowed Fast Appeal Over Proof Test for Age Bias Class
Bloomberg Law· 12 hours agoEli Lilly & Co. can immediately appeal a ruling that conditionally certified a nationwide class in a bias lawsuit alleging the company favors Millennial ...
After Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
Morningstar· 1 day agoWith strong pricing power and sales growth of key drugs, here’s what we think of Lilly’s stock. Eli ...
3 Magnificent Stocks That Are Passive Income Machines
Motley Fool via Yahoo Finance· 16 hours agoInstead, income-seekers should try to find corporations with excellent underlying businesses that...
Is Eli Lilly Stock A Better Pick Over Amgen?
Forbes· 2 days agoAlso, Eli Lilly has seen a better revenue growth and is more profitable. There is more to the comparison, and in the sections below, we discuss why we...
Is Eli Lilly Stock A Buy Or A Sell As FDA Plans Meeting To Discuss Alzheimer's Drug?
Investor's Business Daily· 5 days agoEli Lilly stock yo-yoed over the last week after announcing the Food and Drug Administration has...
Analyst Report: Lilly(Eli) & Co
Argus Research via Yahoo Finance· 15 hours agoEli Lilly, based in Indianapolis, develops and manufactures therapies to treat pain, diabetes, cancer, and neurodegenerative diseases. The shares are a component of the S&P 500.
2 Top Pharma Stocks That Just Keep Getting Better and Better
Motley Fool via Yahoo Finance· 12 hours agoBut the best competitors do it anyway, again and again. So let's examine a pair of today's leading...